Natrecor nesiritide: Began Phase III testing

Scios Inc. (SCIO), Sunnyvale, Calif. Product: Natrecor nesiritide Business: Cardiovascular Therapeutic category: Hormone replacement, Vasodilation Target: Blood vessels and hormones related to blood ...